TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.
about
Alternatives to allogeneic platelet transfusion.Development and validation of a high throughput whole blood thrombolysis plate assay.Reversing the deleterious effects of α2-antiplasmin on tissue plasminogen activator therapy improves outcomes in experimental ischemic strokeCo-ordinated spatial propagation of blood plasma clotting and fibrinolytic frontsFunctional factor XIII-A is exposed on the stimulated platelet surfaceThrombin bound to a fibrin clot confers angiogenic and haemostatic properties on endothelial progenitor cells.The use of the Chandler loop to examine the interaction potential of NXY-059 on the thrombolytic properties of rtPA on human thrombi in vitroAssessment of coronary heart disease risk by combined analysis of coagulation factorsPlasminogen activator inhibitor-1 and thrombotic cerebrovascular diseasesComplement activation: an emerging player in the pathogenesis of cardiovascular diseaseEarly effects of paroxysmal atrial fibrillation on plasma markers of fibrinolysisSubstrates of Factor XIII-A: roles in thrombosis and wound healing.Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.Model thrombi formed under flow reveal the role of factor XIII-mediated cross-linking in resistance to fibrinolysisThe antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking.Secretion and antifibrinolytic function of thrombin-activatable fibrinolysis inhibitor from human platelets.Plasmin and the thrombin-thrombomodulin complex both contribute to thrombin-activatable fibrinolysis inhibitor activation in whole blood model thrombi.The role of thrombin activatable fibrinolysis inhibitor and factor XI in platelet-mediated fibrinolysis resistance: a thromboelastographic study in whole blood.Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.An in vitro proof-of-principle study of sonobactericide.Eplerenone reduces arterial thrombosis in diabetic rats.Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.The Role of PAI-1 4G/5G Promoter Polymorphism and Its Levels in the Development of Ischemic Stroke in Young Indian Population.Endogenous α2-antiplasmin is protective during severe gram-negative sepsis (melioidosis).
P2860
Q33435484-40ABC21F-09D0-4431-ABDB-63796BF4A6A0Q33725847-DC204236-9A25-4960-9012-39B72BFE8C8CQ33789272-F3625AB0-ECC3-432B-BDC8-C49E4811C594Q33884236-61A2365A-34E1-4648-B9D5-8A8180037526Q35023065-C639A413-37F3-430F-ACAB-21ABADF5BB2EQ35458444-47878CBD-FA26-4ACE-8132-BAE859EBCFC9Q36381508-39888870-A33C-4043-8AE9-26C67C16AA43Q36965863-BFB8D94C-FEB9-4F83-AE85-750FF656D98DQ37017506-6FA1B1D1-1F54-4426-829F-3848DE5BF0CAQ37288362-51C5244D-9A90-4871-A7E6-08DFC21FEA86Q37409534-58DCCC2A-6101-477C-8AC3-8A6B95005279Q38052936-C4857B97-4829-4098-B8AF-4FB8BD18B0DFQ41428336-313227FF-BE0A-46A3-9253-7937BDB86A0AQ41904806-3164D86B-3172-4ED6-A4B4-747CB1762AA6Q42326716-BA85D1B0-CE4B-43D8-A808-71AE1C25F7E9Q42932507-24E37A84-DAB7-4356-8841-C5D4ED17FD98Q44713312-EB303438-CA16-4E07-8A4F-B7BE237C34E2Q45842157-0A502327-9BB1-4825-B98C-B27E88867C8CQ46178310-2399EBDE-299D-4F34-93DB-BB37FAF25B5DQ48301035-BA7C35F1-A766-4396-BBBC-95FAA25B9340Q50282142-51639735-18A8-4561-A99F-653B81F20326Q51068066-825AD6C0-1E6D-48F9-9BF8-EAAC8F0B8296Q51232674-980AF2B9-71D0-4BAC-86E9-DAE4D79C5E6CQ53320932-E1AB48A8-9CD3-477A-A258-6F14C76F7214Q55057343-5E619B90-B54D-4DB0-A810-109A766FE1E3
P2860
TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@ast
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@en
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@nl
type
label
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@ast
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@en
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@nl
prefLabel
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@ast
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@en
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@nl
P2093
P2860
P1476
TAFIa, PAI-1 and alpha-antipla ...... s of thrombi and plasma clots.
@en
P2093
P2860
P304
P356
10.1111/J.1538-7836.2007.02430.X
P577
2007-02-02T00:00:00Z